HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:DOC • US42250P1030
16.345 USD
-0.58 (-3.4%)
Last: Feb 3, 2026, 12:29 PM
Taking everything into account, DOC scores 3 out of 10 in our fundamental rating. DOC was compared to 124 industry peers in the Diversified REITs industry. Both the profitability and financial health of DOC have multiple concerns. DOC has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year DOC was profitable.
- In the past year DOC had a positive cash flow from operations.
- DOC had positive earnings in 4 of the past 5 years.
- DOC had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of DOC (-0.20%) is worse than 61.29% of its industry peers.
- With a Return On Equity value of -0.51%, DOC is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
- The Return On Invested Capital of DOC (2.23%) is comparable to the rest of the industry.
- The Average Return On Invested Capital over the past 3 years for DOC is in line with the industry average of 3.05%.
- The 3 year average ROIC (2.19%) for DOC is below the current ROIC(2.23%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.2% | ||
| ROE | -0.51% | ||
| ROIC | 2.23% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
1.3 Margins
- DOC's Profit Margin has improved in the last couple of years.
- The Operating Margin of DOC (18.19%) is comparable to the rest of the industry.
- In the last couple of years the Operating Margin of DOC has declined.
- Looking at the Gross Margin, with a value of 60.08%, DOC is doing worse than 66.94% of the companies in the same industry.
- DOC's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.19% | ||
| PM (TTM) | N/A | ||
| GM | 60.08% |
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
2. Health
2.1 Basic Checks
- DOC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- There is no outstanding debt for DOC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of 0.31, we must say that DOC is in the distress zone and has some risk of bankruptcy.
- DOC has a Altman-Z score of 0.31. This is in the lower half of the industry: DOC underperforms 61.29% of its industry peers.
- The Debt to FCF ratio of DOC is 20.30, which is on the high side as it means it would take DOC, 20.30 years of fcf income to pay off all of its debts.
- With a decent Debt to FCF ratio value of 20.30, DOC is doing good in the industry, outperforming 76.61% of the companies in the same industry.
- DOC has a Debt/Equity ratio of 1.20. This is a high value indicating a heavy dependency on external financing.
- DOC has a Debt to Equity ratio of 1.20. This is comparable to the rest of the industry: DOC outperforms 54.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.2 | ||
| Debt/FCF | 20.3 | ||
| Altman-Z | 0.31 |
ROIC/WACC0.35
WACC6.36%
2.3 Liquidity
- DOC has a Current Ratio of 0.11. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Current ratio of DOC (0.11) is worse than 95.16% of its industry peers.
- A Quick Ratio of 0.11 indicates that DOC may have some problems paying its short term obligations.
- DOC has a Quick ratio of 0.11. This is amonst the worse of the industry: DOC underperforms 95.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 |
3. Growth
3.1 Past
- DOC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
- The earnings per share for DOC have been decreasing by -16.06% on average. This is quite bad
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.07%
3.2 Future
- Based on estimates for the next years, DOC will show a small growth in Earnings Per Share. The EPS will grow by 1.32% on average per year.
- DOC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.03% yearly.
EPS Next Y-24.56%
EPS Next 2Y-9.47%
EPS Next 3Y-6.86%
EPS Next 5Y1.32%
Revenue Next Year1.4%
Revenue Next 2Y2.26%
Revenue Next 3Y4.08%
Revenue Next 5Y5.03%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- DOC is valuated quite expensively with a Price/Earnings ratio of 46.70.
- The rest of the industry has a similar Price/Earnings ratio as DOC.
- DOC is valuated expensively when we compare the Price/Earnings ratio to 28.41, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 61.90, which means the current valuation is very expensive for DOC.
- The rest of the industry has a similar Price/Forward Earnings ratio as DOC.
- When comparing the Price/Forward Earnings ratio of DOC to the average of the S&P500 Index (25.64), we can say DOC is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.7 | ||
| Fwd PE | 61.9 |
4.2 Price Multiples
- 66.13% of the companies in the same industry are more expensive than DOC, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, DOC is valued a bit cheaper than the industry average as 74.19% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.25 | ||
| EV/EBITDA | 13.16 |
4.3 Compensation for Growth
- DOC's earnings are expected to decrease with -6.86% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.47%
EPS Next 3Y-6.86%
5. Dividend
5.1 Amount
- DOC has a Yearly Dividend Yield of 7.08%, which is a nice return.
- DOC's Dividend Yield is a higher than the industry average which is at 6.98.
- Compared to an average S&P500 Dividend Yield of 1.83, DOC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.08% |
5.2 History
- The dividend of DOC decreases each year by -2.76%.
- DOC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-2.76%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- DOC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2176.08%
EPS Next 2Y-9.47%
EPS Next 3Y-6.86%
NYSE:DOC (2/3/2026, 12:29:10 PM)
16.345
-0.58 (-3.4%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-02 2026-02-02/amc
Earnings (Next)04-22 2026-04-22
Inst Owners97.22%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner Change0.5%
Market Cap11.36B
Revenue(TTM)N/A
Net Income(TTM)-38.93M
Analysts75.83
Price Target20.16 (23.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.08% |
Yearly Dividend1.28
Dividend Growth(5Y)-2.76%
DP-2176.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-17 2026-03-17 (0.10167)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.17%
Min EPS beat(2)-19.41%
Max EPS beat(2)37.75%
EPS beat(4)2
Avg EPS beat(4)-12.11%
Min EPS beat(4)-79.16%
Max EPS beat(4)37.75%
EPS beat(8)5
Avg EPS beat(8)12.39%
EPS beat(12)7
Avg EPS beat(12)15.73%
EPS beat(16)10
Avg EPS beat(16)43.13%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)0.94%
Revenue beat(4)3
Avg Revenue beat(4)0.74%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)2.05%
Revenue beat(8)6
Avg Revenue beat(8)1.89%
Revenue beat(12)8
Avg Revenue beat(12)-4.75%
Revenue beat(16)11
Avg Revenue beat(16)-3.38%
PT rev (1m)-2.61%
PT rev (3m)-5.03%
EPS NQ rev (1m)-0.82%
EPS NQ rev (3m)0.75%
EPS NY rev (1m)-1.12%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)-0.54%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.7 | ||
| Fwd PE | 61.9 | ||
| P/S | 4.06 | ||
| P/FCF | 25.25 | ||
| P/OCF | 9.15 | ||
| P/B | 1.5 | ||
| P/tB | 1.63 | ||
| EV/EBITDA | 13.16 |
EPS(TTM)0.35
EY2.14%
EPS(NY)0.26
Fwd EY1.62%
FCF(TTM)0.65
FCFY3.96%
OCF(TTM)1.79
OCFY10.92%
SpS4.03
BVpS10.93
TBVpS10.05
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.2% | ||
| ROE | -0.51% | ||
| ROCE | 2.83% | ||
| ROIC | 2.23% | ||
| ROICexc | 2.25% | ||
| ROICexgc | 2.46% | ||
| OM | 18.19% | ||
| PM (TTM) | N/A | ||
| GM | 60.08% | ||
| FCFM | 16.06% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
ROICexc(3y)2.2%
ROICexc(5y)1.94%
ROICexgc(3y)2.39%
ROICexgc(5y)2.1%
ROCE(3y)2.77%
ROCE(5y)2.44%
ROICexgc growth 3Y3.4%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y2.73%
ROICexc growth 5Y2.33%
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
F-Score4
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.2 | ||
| Debt/FCF | 20.3 | ||
| Debt/EBITDA | 5.78 | ||
| Cap/Depr | 73.87% | ||
| Cap/Sales | 28.24% | ||
| Interest Coverage | 1.93 | ||
| Cash Conversion | 78.53% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 | ||
| Altman-Z | 0.31 |
F-Score4
WACC6.36%
ROIC/WACC0.35
Cap/Depr(3y)101.04%
Cap/Depr(5y)178.11%
Cap/Sales(3y)35.69%
Cap/Sales(5y)67.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-27.44%
EPS 5Y-16.06%
EPS Q2Q%1500%
EPS Next Y-24.56%
EPS Next 2Y-9.47%
EPS Next 3Y-6.86%
EPS Next 5Y1.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.07%
Revenue Next Year1.4%
Revenue Next 2Y2.26%
Revenue Next 3Y4.08%
Revenue Next 5Y5.03%
EBIT growth 1Y-12.91%
EBIT growth 3Y9.55%
EBIT growth 5Y8.14%
EBIT Next Year227.22%
EBIT Next 3Y51.03%
EBIT Next 5Y31.86%
FCF growth 1Y542.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.14%
OCF growth 3Y10.42%
OCF growth 5Y4.82%
HEALTHPEAK PROPERTIES INC / DOC FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
What is the valuation status for DOC stock?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
Can you provide the profitability details for HEALTHPEAK PROPERTIES INC?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 4 / 10.
What is the valuation of HEALTHPEAK PROPERTIES INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (DOC) is 46.7 and the Price/Book (PB) ratio is 1.5.
How sustainable is the dividend of HEALTHPEAK PROPERTIES INC (DOC) stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is -2176.08%.